Transfusion Reaction

Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility.

Also Known As:

Acute Hemolytic Transfusion Reaction; Blood Transfusion-Associated Adverse Reactions; Delayed Serologic Transfusion Reaction; Febrile Non-Hemolytic Transfusion Reaction; Hemolytic Transfusion Reaction; Hypotensive Transfusion Reaction; Post-Transfusion Purpura; Posttransfusion Purpura; TAGHD; Transfusion-Associated Allergic Reaction; Transfusion-Associated Circulatory Overload; Transfusion-Associated Dyspnea; Transfusion-Associated Graft Vs. Host Disease; Transfusion-Transmitted Infection; Allergic Reaction, Transfusion-Associated; Blood Transfusion Associated Adverse Reactions; Circulatory Overload, Transfusion-Associated; Circulatory Overloads, Transfusion-Associated; Dyspnea, Transfusion-Associated; Febrile Non Hemolytic Transfusion Reaction; Hemolytic Transfusion Reactions; Infection, Transfusion-Transmitted; Post Transfusion Purpura; Posttransfusion Purpuras; Purpura, Post-Transfusion; Purpura, Posttransfusion; Reaction, Hemolytic Transfusion; Reaction, Hypotensive Transfusion; Reactions, Hemolytic Transfusion; Transfusion Associated Allergic Reaction; Transfusion Associated Circulatory Overload; Transfusion Associated Dyspnea; Transfusion Associated Graft Vs. Host Disease; Transfusion Reaction, Hemolytic; Transfusion Reaction, Hypotensive; Transfusion Reactions; Transfusion Reactions, Hemolytic; Transfusion Reactions, Hypotensive; Transfusion Transmitted Infection; Transfusion-Associated Circulatory Overloads; Transfusion-Transmitted Infections; Delayed Hemolytic Transfusion Reaction

Hemic and Lymphatic Diseases: 6
- Hematologic Diseases: 3366
  - Transfusion Reaction: 1887
Immune System Diseases: 4321
- Transfusion Reaction: 1887

Rachael M Chandler Selected Research

Rachael M Chandler Research Topics

Disease

Drug/Important Bio-Agent (IBA)